 Waseem Ahmed
| Title | Asst Professor |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-MED |
|---|
|
|
|
 Bibliographic
-
Ahmed W, Billing W, Stump TE, Strobel T, Sagi S, Fischer M, Bohm M. Opioid Legislation in Patients With Inflammatory Bowel Disease: A State-wide Retrospective Cohort Study. Inflamm Bowel Dis. 2023 09 01; 29(9):1355-1361. PMID: 36271877.
-
Smith ES, Chen J, Pan Y, Mahtani P, Lukin D, Ahmed W, Longman R, Burakoff R, Scherl E, Battat R. The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease. J Clin Gastroenterol. 2023 Aug 21. PMID: 37646564.
-
Johnson AM, Barsky M, Ahmed W, Zullow S, Galati J, Jairath V, Narula N, Peerani F, Click BH, Coburn ES, Dang TT, Gold S, Agrawal M, Garg R, Aggarwal M, Mohammad D, Halloran B, Kochhar GS, Todorowski H, Ud Din NM, Izanec J, Teeple A, Gasink C, Muser E, Ding Z, Swaminath A, Lakhani K, Hogan D, Datta S, Ungaro RC, Boland BS, Bohm M, Fischer M, Sagi S, Afzali A, Ullman T, Lawlor G, Baumgart DC, Chang S, Hudesman D, Lukin D, Scherl EJ, Colombel JF, Sands BE, Siegel CA, Regueiro M, Sandborn WJ, Bruining D, Kane S, Loftus EV, Dulai PS. The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium. Am J Gastroenterol. 2023 02 01; 118(2):317-328. PMID: 36191274.
-
Ahmed W. Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease. Crohns Colitis 360. 2022 Jan; 4(1):otac005. PMID: 36777549.
-
Ahmed W, Lukin DJ. A step towards informed positioning of advanced therapies for moderate-to-severe Crohn's disease. Lancet Gastroenterol Hepatol. 2021 12; 6(12):973-975. PMID: 34688375.
-
Lukin DJ, Funez-dePagnier G, Lima S, Lai D, Duenas-Bianchi L, Ahmed W, Jacob V, Battat R, Scherl E, Longman RS. No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD. Clin Gastroenterol Hepatol. 2021 11; 19(11):2312-2314.e3. PMID: 34102340.
-
Ahmed W, Scott FI. Closing the Gap: the Real-World Risk of Serious Infections With Vedolizumab in Comparison With Anti-TNF Therapy in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 02; 20(2):e28-e30. PMID: 34022455.
-
Ahmed W, Lukin DJ. Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance. Inflamm Bowel Dis. 2021 05 17; 27(6):787-790. PMID: 32812050.
-
Ahmed W, Galati J, Kumar A, Christos PJ, Longman R, Lukin DJ, Scherl E, Battat R. Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022 03; 20(3):e361-e379. PMID: 33798711.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2021 | 5 | | 2022 | 2 | | 2023 | 2 |
To return to the timeline, click here.
|
Ahmed's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|